Category Archives: Longevity companies

Scientists have shown that young blood rejuvenates old tissues. Now, come human tests.

From Nature:

“Wyss-Coray formed a start-up company, Alkahest in Menlo Park, California, and in September 2014 it began a randomized, placebo-controlled, double-blind trial at Stanford, testing the safety and efficacy of using young plasma to treat Alzheimer’s disease. Six out of a planned 18 people with Alzheimer’s, all aged 50 or above, have already begun to receive plasma harvested from men aged 30 or younger. In addition to monitoring disease symptoms, the researchers are looking for changes in brain scans and blood biomarkers of the disease.”

And from Stanford Medicine:

“Something — or some things — in the blood of young mice has the ability to restore mental capabilities in old mice, a new study by Stanford University School of Medicine investigators has found.

If the same goes for humans, it could spell a new paradigm for recharging our aging brains, and it might mean new therapeutic approaches for treating dementias such as Alzheimer’s disease.”

This Device Could Detect Dozens of Cancers With a Single Blood Test

It’s still a long way away, but this is a great idea (and from Singularity University).

From Wired:
“A new startup, dubbed Miroculus, is building a device that could easily and affordably check for dozens of cancers using a single blood sample. Known as Miriam, this low-cost, open source device made its public debut at the TEDGlobal conference in Rio De Janeiro on Thursday, with TED curator Chris Anderson calling it “one of the most thrilling demos in TED history.”

Google’s anti-aging project, Calico, announces $1.5 billion research center

From the Verge:

“The Google-backed life-extension company, Calico, announced today that it was partnering with Chicago-based pharmaceutical giant AbbVie to develop and bring to market new drugs targeting diseases associated with old age. Each partner has committed to providing $250 million in funding with the option to each add another $500 million to the project. The money will be used to create a new research center in San Francisco, where Calico will hire a team of researchers to discover new drugs and guide early development. AbbVie will focus more on the clinical trials, late-stage development, and bringing promising new drugs to market.”

Silicon Valley Moves the Needle on Curing Aging

Here’s a piece I wrote for Slate.

“Silicon Valley, known for entrepreneurs, gadget lovers, and paradigm breakers, has recently turned its attention towards longevity, powering an important cultural change on the topic. The interests of these movers and shakers run the gamut, from using technology to improve our clunky healthcare system to literally solving the problem of aging.”

Read more here.

Craig Venter & Human Longevity Inc

The Financial Times posted an interesting article about Craig Venter and his new longevity company, Human Longevity Inc. When the journalist asks him if his company is in competition with Google’s Calico (also set up to extend human healthspan), Venter says this:

“I turn 68 later this year and if they solve ageing before we do, I will kiss the rings and buy their products.”

Couldn’t agree more.